New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
11:34 EDTEARSAuris Medical opens for trade at $6.00, IPO priced at $6.00
News For EARS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
08:15 EDTEARSAuris Medical, Cochlear to collaborate on clinical trial with AM-111
Auris Medical and Cochlear announced they will collaborate on a planned randomized placebo-controlled clinical trial in the U.S., the REACH trial. As previously announced, REACH shall evaluate Auris Medical's cell penetrating otoprotectant AM-111 in patients with residual hearing who are undergoing cochlear implant, or CI, surgery. Under the collaboration, Cochlear will support preparations for REACH and provide expertise in cochlear implants and hearing preservation.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use